Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases

NCT05709717 is registered in ClinicalTrials.gov with Kantonsspital Winterthur KSW as lead sponsor.

NCT NCT05709717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05709717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
Lead sponsor
Kantonsspital Winterthur KSW
Phase
Observational
Overall status
Unknown status
Start date
January 25, 2023
Completion date
January 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal fissure, perianal crohn disease, perianal fistula, perianal fistula due to crohn's disease, rectovaginal fistula